Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow
Research paper by Bansal, D, Vij, K, Chang, G. S, Miller, C. A, DiPersio, J. F, Vij, R, Heath, S. E, Westervelt, et al.
Indexed on: 10 Jun '18Published on: 04 Jun '18Published in: Haematologica
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join for free
Abstract
Authors: Bansal, D ; Vij ; K ; Chang ; G. S ; Miller ; C. A ; DiPersio ; J. F ; Vij ; R ; Heath ; S. E ; Westervelt ; P ; Welch ; J. S ; Fehniger ; T. A.
Article URL: http://www.haematologica.org/cgi/reprint/103/6/e270?rss=1
Citation: Vol 103 No. 6 (2018) pp e270 e273
Publication Date: 2018-06-03T23:55:04-07:00
Journal: Haematologica - the Hematology journal